{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:19:20Z","timestamp":1793477960267,"version":"4.5.0"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Adrenal vein sampling (AVS) is the recommended procedure for subtyping primary aldosteronism (PA) as unilateral PA (UPA) or bilateral PA (BPA), with different treatment needed for each: adrenalectomy for UPA and medication for BPA. However, AVS is invasive and technically difficult, and how to subtype PA noninvasively is currently a great challenge.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate the accuracy of gallium-68 pentixafor positron emission tomography\u2013computed tomography (PET-CT) in subtyping PA using AVS as a reference standard.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This diagnostic study was conducted at a tertiary hospital in China among patients diagnosed with PA. Enrollment was started in November 2021, with follow-up ending in May 2022.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n \n :<\/jats:bold>\n Patients were recruited to undergo gallium-68 pentixafor PET-CT and AVS.\n <\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Maximum standardized uptake value (SUVmax) of each adrenal gland during PET-CT was measured to calculate the lateralization index of SUVmax. Area under the receiver operating characteristic curve (AUROC), specificity, and sensitivity were used to analyze the accuracy of the lateralization index based on SUVmax for subtyping PA.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Among 100 patients with PA who completed the study (47 female [47.0%] and 53 male [53.0%]; median [IQR] age, 49 [38-56] years), 43 individuals had UPA and 57 individuals had BPA. Aldosterone-cortisol ratio (Spearman \u03c1\u2009=\u20090.26;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001) in adrenal veins was positively correlated with SUVmax of adrenal glands at 10 minutes during PET-CT. Using lateralization index based on SUVmax at 10 minutes to identify UPA, the AUROC was 0.90 (95% CI, 0.83-0.97). A cutoff value for lateralization index based on SUVmax at 10 minutes set at 1.65 conferred a specificity of 1.00 (95% CI, 0.94-1.00) and sensitivity of 0.77 (95% CI, 0.61-0.88). The diagnostic concordance rate of PET-CT and AVS was 90 patients (90.0%) compared with 54 patients (54.0%) between traditional CT and AVS.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This study found good diagnostic accuracy of gallium-68 pentixafor PET-CT in differentiating UPA from BPA. These findings suggest that gallium-68 pentixafor PET-CT may be used to avoid invasive AVS in some patients with PA.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.55609","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T11:01:02Z","timestamp":1676545262000},"page":"e2255609","source":"Crossref","is-referenced-by-count":121,"title":["Accuracy of Gallium-68 Pentixafor Positron Emission Tomography\u2013Computed Tomography for Subtyping Diagnosis of Primary Aldosteronism"],"prefix":"10.1001","volume":"6","author":[{"given":"Jinbo","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, Sichuan, China"},{"name":"Institute of Nuclear Medicine, Southwest Medical University, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Monash University, Clayton, Victoria, Australia"},{"name":"Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aipin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Graduate Administration Office, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyuan","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, Sichuan, China"},{"name":"Institute of Nuclear Medicine, Southwest Medical University, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiguo","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, Sichuan, China"},{"name":"Institute of Nuclear Medicine, Southwest Medical University, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, Sichuan, China"},{"name":"Institute of Nuclear Medicine, Southwest Medical University, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, Sichuan, China"},{"name":"Institute of Nuclear Medicine, Southwest Medical University, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqiang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengping","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"He","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cai","sequence":"additional","affiliation":[{"name":"Hypertension Center, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, Sichuan, China"},{"name":"Institute of Nuclear Medicine, Southwest Medical University, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Chongqing Primary Aldosteronism Study (CONPASS) Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Mei","sequence":"additional","affiliation":[{"name":"for the Chongqing Primary Aldosteronism Study (CONPASS) Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxin","family":"Luo","sequence":"additional","affiliation":[{"name":"for the Chongqing Primary Aldosteronism Study (CONPASS) Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangla","family":"Liao","sequence":"additional","affiliation":[{"name":"for the Chongqing Primary Aldosteronism Study (CONPASS) Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[{"name":"for the Chongqing Primary Aldosteronism Study (CONPASS) Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"He","sequence":"additional","affiliation":[{"name":"for the Chongqing Primary Aldosteronism Study (CONPASS) Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"He","sequence":"additional","affiliation":[{"name":"for the Chongqing Primary Aldosteronism Study (CONPASS) Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Peng","sequence":"additional","affiliation":[{"name":"for the Chongqing Primary Aldosteronism Study (CONPASS) Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xiao","sequence":"additional","affiliation":[{"name":"for the Chongqing Primary Aldosteronism Study (CONPASS) Group"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"issue":"11","key":"zoi221576r1","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"zoi221576r2","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice.","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"zoi221576r3","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","article-title":"Primary aldosteronism in patients in China with recently detected hypertension.","volume":"75","author":"Xu","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"zoi221576r4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study.","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"issue":"6","key":"zoi221576r5","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism.","volume":"136","author":"Young","year":"2004","journal-title":"Surgery"},{"issue":"4","key":"zoi221576r6","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1161\/HYPERTENSIONAHA.119.13463","article-title":"Clinical outcomes of 1625 patients with primary aldosteronism subtyped with adrenal vein sampling.","volume":"74","author":"Rossi","year":"2019","journal-title":"Hypertension"},{"issue":"5","key":"zoi221576r7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism.","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann Intern Med"},{"issue":"5","key":"zoi221576r8","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The Management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline.","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"zoi221576r9","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Guidelines for the diagnosis and treatment of primary aldosteronism\u2014the Japan Endocrine Society 2009.","volume":"58","author":"Nishikawa","year":"2011","journal-title":"Endocr J"},{"issue":"5","key":"zoi221576r10","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1210\/jc.2011-2830","article-title":"The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism.","volume":"97","author":"Rossi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"zoi221576r11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1530\/EJE-20-0532","article-title":"Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism.","volume":"183","author":"Soinio","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"zoi221576r12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1210\/jc.2011-1537","article-title":"Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn\u2019s adenomas.","volume":"97","author":"Burton","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"zoi221576r13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/cen.2019.90.issue-5","article-title":"11 C-metomidate PET\/CT is a useful adjunct for lateralization of primary aldosteronism in routine clinical practice.","volume":"90","author":"O\u2019Shea","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"zoi221576r14","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1210\/jc.2015-3431","article-title":"A novel CYP11B2-specific imaging agent for detection of unilateral subtypes of primary aldosteronism.","volume":"101","author":"Abe","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"zoi221576r15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s12020-020-02474-3","article-title":"11C-metomidate PET in the diagnosis of adrenal masses and primary aldosteronism: a review of the literature.","volume":"70","author":"Chen Cardenas","year":"2020","journal-title":"Endocrine"},{"issue":"2","key":"zoi221576r16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","article-title":"Targeting CXCR4 (CXC chemokine receptor type 4) for molecular imaging of aldosterone-producing adenoma.","volume":"71","author":"Heinze","year":"2018","journal-title":"Hypertension"},{"issue":"11","key":"zoi221576r17","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1007\/s00259-020-04722-0","article-title":"Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism.","volume":"47","author":"Ding","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"zoi221576r18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/RLU.0000000000002946","article-title":"Intense 68Ga-pentixafor activity in aldosterone-producing adrenal adenomas.","volume":"45","author":"Ding","year":"2020","journal-title":"Clin Nucl Med"},{"key":"zoi221576r19","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8647026","article-title":"Age-related cutoffs of plasma aldosterone\/renin concentration for primary aldosteronism screening.","volume":"2018","author":"Ma","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"7","key":"zoi221576r20","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa282","article-title":"Development and validation of criteria for sparing confirmatory tests in diagnosing primary aldosteronism.","volume":"105","author":"Wang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"zoi221576r21","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.120.16429","article-title":"Intraindividual variability of aldosterone concentrations in primary aldosteronism: implications for case detection.","volume":"77","author":"Yozamp","year":"2021","journal-title":"Hypertension"},{"issue":"1","key":"zoi221576r22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1210\/clinem\/dgac568","article-title":"Aldosterone, renin and, aldosterone-to-renin ratio variability in screening for primary aldosteronism.","volume":"108","author":"Ng","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"zoi221576r23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0009-9260(05)81739-8","article-title":"The size of normal adrenal glands on computed tomography.","volume":"49","author":"Vincent","year":"1994","journal-title":"Clin Radiol"},{"issue":"6","key":"zoi221576r24","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMcp065470","article-title":"Clinical practice: the incidentally discovered adrenal mass.","volume":"356","author":"Young","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi221576r25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jamcollsurg.2019.03.012","article-title":"Influence of adrenal venous sampling on management in patients with primary aldosteronism independent of lateralization on cross-sectional imaging.","volume":"229","author":"Campbell","year":"2019","journal-title":"J Am Coll Surg"},{"issue":"1","key":"zoi221576r26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism.","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"issue":"4","key":"zoi221576r27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S2213-8587(14)70069-5","article-title":"Adrenal vein sampling in primary aldosteronism: towards a standardised protocol.","volume":"3","author":"Monticone","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"zoi221576r28","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort.","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"zoi221576r29","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.","volume":"36","author":"Williams","year":"2018","journal-title":"J Hypertens"},{"issue":"12","key":"zoi221576r31","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1038\/s41440-019-0310-y","article-title":"Primary aldosteronism subtype discordance between computed tomography and adrenal venous sampling.","volume":"42","author":"Aono","year":"2019","journal-title":"Hypertens Res"},{"issue":"6","key":"zoi221576r32","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1210\/jc.2018-02089","article-title":"Discordance between imaging and adrenal vein sampling in primary aldosteronism irrespective of interpretation criteria.","volume":"104","author":"Sam","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"zoi221576r33","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1210\/jc.2012-1917","article-title":"A clinical prediction score to diagnose unilateral primary aldosteronism.","volume":"97","author":"K\u00fcpers","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"zoi221576r34","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa379","article-title":"Development and validation of prediction models for subtype diagnosis of patients with primary aldosteronism.","volume":"105","author":"Burrello","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"zoi221576r35","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/jhh.2014.20","article-title":"A subtype prediction score for primary aldosteronism.","volume":"28","author":"Nanba","year":"2014","journal-title":"J Hum Hypertens"},{"issue":"7","key":"zoi221576r36","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1097\/HJH.0000000000002348","article-title":"Aldosterone-potassium ratio predicts primary aldosteronism subtype.","volume":"38","author":"Puar","year":"2020","journal-title":"J Hypertens"},{"issue":"6","key":"zoi221576r37","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/cen.v91.6","article-title":"Seated saline infusion test in predicting subtype diagnosis of primary aldosteronism.","volume":"91","author":"Kaneko","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"zoi221576r38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3803\/EnM.2020.901","article-title":"Diagnostic accuracy of computed tomography in predicting primary aldosteronism subtype according to age.","volume":"36","author":"Lee","year":"2021","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"5","key":"zoi221576r39","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/cen.2018.88.issue-5","article-title":"Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism.","volume":"88","author":"Umakoshi","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"zoi221576r40","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1097\/HJH.0000000000001488","article-title":"Identifying unilateral disease in Chinese patients with primary aldosteronism by using a modified prediction score.","volume":"35","author":"Zhang","year":"2017","journal-title":"J Hypertens"},{"issue":"11","key":"zoi221576r41","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1097\/HJH.0000000000001855","article-title":"Development and validation of subtype prediction scores for the workup of primary aldosteronism.","volume":"36","author":"Kobayashi","year":"2018","journal-title":"J Hypertens"},{"issue":"3","key":"zoi221576r42","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1210\/jc.2017-01774","article-title":"Significance of computed tomography and serum potassium in predicting subtype diagnosis of primary aldosteronism.","volume":"103","author":"Umakoshi","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"zoi221576r43","first-page":"134","article-title":"Is there a role for nuclear medicine in diagnosis and management of patients with primary aldosteronism?","volume":"16","author":"Spyridonidis","year":"2013","journal-title":"Hell J Nucl Med"},{"issue":"2","key":"zoi221576r44","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/JU.0000000000001752","article-title":"Partial adrenalectomy carries a considerable risk of incomplete cure in primary aldosteronism.","volume":"206","author":"van de Wiel","year":"2021","journal-title":"J Urol"},{"issue":"8","key":"zoi221576r45","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/RLU.0000000000004244","article-title":"Usefulness of 68 Ga-Pentixafor PET\/CT on diagnosis and management of Cushing syndrome.","volume":"47","author":"Ding","year":"2022","journal-title":"Clin Nucl Med"},{"key":"zoi221576r30","unstructured":"van Buuren? S, Groothuis-Oudshoorn? K. Multivariate imputation by chained equations. Accessed January 11, 2023. https:\/\/amices.org\/mice\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2801498\/hu_2023_oi_221576_1675800358.91597.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T11:01:06Z","timestamp":1676545266000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2801498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.55609","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]}}}